<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02916966</url>
  </required_header>
  <id_info>
    <org_study_id>D06019</org_study_id>
    <nct_id>NCT02916966</nct_id>
  </id_info>
  <brief_title>Population-Based Ohio Amyotrophic Lateral Sclerosis (ALS) Repository and ALS Risk Factors</brief_title>
  <official_title>A Population-Based Ohio ALS Repository and a Case-Controlled Study of ALS Risk Factors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dartmouth-Hitchcock Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Dartmouth-Hitchcock Medical Center</source>
  <brief_summary>
    <textblock>
      The proposed research is particularly relevant to the National ALS Registry and public
      environmental health issues because it addresses the potential environmental causes of
      sporadic ALS. The research will develop an ALS surveillance program in Ohio that can be
      compared with the national and State-Metro Surveillance Programs of the National ALS
      Registry, and novel methodologies to determine the role of the cyanobacterial toxin, BMAA
      (beta-methylamino-L-alanine), and other environmental toxins/toxicants as risk factors for
      ALS. This work will advance the mission of the Centers for Disease Control Agency for Toxic
      Substances and Disease Registry (CDC ATSDR) National ALS Registry by offering data on ALS
      cases in Ohio that address public health concerns over the effects of chronic exposure to
      cyanobacterial blooms in Lake Erie.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 2016</start_date>
  <completion_date type="Actual">October 2019</completion_date>
  <primary_completion_date type="Actual">September 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Questionnaire for Environmental Exposures, Toxins, and Neurological Disease</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">350</enrollment>
  <condition>Amyotrophic Lateral Sclerosis</condition>
  <arm_group>
    <arm_group_label>ALS Patients in Case-Control</arm_group_label>
    <description>ALS patients enrolled by Cleveland Clinic Foundation (CCF)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-neurodegenerative patients in case control</arm_group_label>
    <description>Non-neurodegenerative patients enrolled by CCF</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-neurodegeneration population in population control</arm_group_label>
    <description>Non-neurodegenerative general population enrolled by ABS mailing system from DHMC</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ALS Patients in State of OH</arm_group_label>
    <description>ALS registry of all cases in Ohio</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Patient Registry</intervention_name>
    <description>Patient Registry</description>
    <arm_group_label>ALS Patients in Case-Control</arm_group_label>
    <arm_group_label>ALS Patients in State of OH</arm_group_label>
    <arm_group_label>Non-neurodegeneration population in population control</arm_group_label>
    <arm_group_label>Non-neurodegenerative patients in case control</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        1. ALS patients in case-control at CCF

          2. Non-neurodegenerative patients in case control at CCF

          3. Non-neurodegenerative general population in Ohio

          4. ALS patient registry in Ohio
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ALS

          -  Non-neurodegenerative controls

          -  Can willingly give consent

          -  Over 18 years of age

        Exclusion Criteria:

          -  Cannot give consent

          -  Under 18 years of age
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>September 26, 2016</study_first_submitted>
  <study_first_submitted_qc>September 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 28, 2016</study_first_posted>
  <last_update_submitted>October 10, 2019</last_update_submitted>
  <last_update_submitted_qc>October 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dartmouth-Hitchcock Medical Center</investigator_affiliation>
    <investigator_full_name>Elijah W. Stommel</investigator_full_name>
    <investigator_title>Professor of Neurology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Motor Neuron Disease</mesh_term>
    <mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

